ARCHIVES

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

This article is from The Cancer Letter archive.

Vol. 26 No. 22 | June 2, 2000

Download PDF Visit The Full Archive

Related Articles

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

October 31, 2014

Gottlieb questions ODAC’s independence.

August 5, 2005

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

Sarcoma, Li-Fraumeni Linked; Genetic Counseling Recommended

February 24, 2012

NCI Restructures AIDS Effort; New Research Thrusts Recommended

October 5, 1984

In Brief: Most NCI Grants, Including Noncompeting And r01s, Will Take Cuts Of At Least 4 Percent; Paylines Set

January 22, 1982